Cod Liver Oil for Covid-19 Prevention Study
A Randomized, Parallel-group Treatment, Quadruple Masked, Two-arm Study, to Assess the Effectiveness of Cod Liver Oil Compared to Placebo in the Prevention of Covid-19 and Airway Infections in Healthy Adults
Sponsor: Norwegian Institute of Public Health
A PHASE4 clinical study on Covid-19 and Respiratory Tract Infections, this trial is completed. The trial is conducted by Norwegian Institute of Public Health and has accumulated 7 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
May 2022 — Jul 2024 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Jan 2022 — May 2022 [monthly]
Recruiting PHASE4
-
Jan 2021 — Jan 2022 [monthly]
Recruiting PHASE4
▶ Show 2 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Nov 2020 — Dec 2020 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Norwegian Institute of Public Health
- Oslo University Hospital
- University of Oslo
For direct contact, visit the study record on ClinicalTrials.gov .